{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:34:15Z","timestamp":1789392855724,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.gore.2017.02.010","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T23:17:05Z","timestamp":1488928625000},"page":"67-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report"],"prefix":"10.1016","volume":"20","author":[{"given":"Laura K.","family":"Hadad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gore.2017.02.010_bb0005","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","article-title":"Posterior reversible encephalopathy syndrome--insight into pathogenesis, clinical variants and treatment approaches","volume":"14","author":"Granata","year":"2015","journal-title":"Autoimmune Rev."},{"key":"10.1016\/j.gore.2017.02.010_bb0010","unstructured":"Porcello marrone LC, Marrone BF, Gadonski G, Huf marrone AC, Da costa JC. Posterior reversible encephalopathy syndrome. Clin Adv Hematol Oncol. 2012; 10(9):614\u20135."},{"issue":"9","key":"10.1016\/j.gore.2017.02.010_bb0015","first-page":"611","article-title":"Gemcitabine associated with posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature","volume":"10","author":"Truong","year":"2012","journal-title":"Clin Adv Hematol Oncol."},{"issue":"3","key":"10.1016\/j.gore.2017.02.010_bb0020","first-page":"415","article-title":"Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome","volume":"19","author":"Ito","year":"1998","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"9","key":"10.1016\/j.gore.2017.02.010_bb0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.gore.2017.02.010_bb0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"The Lancet Neurology."},{"key":"10.1016\/j.gore.2017.02.010_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","article-title":"Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes","volume":"133","author":"Irani","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"20","key":"10.1016\/j.gore.2017.02.010_bb0040","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.gore.2017.02.010_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.gore.2017.02.010_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0031-1277985","article-title":"Autoimmune encephalopathy","volume":"31","author":"Flanagan","year":"2011","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.gore.2017.02.010_bb0055","doi-asserted-by":"crossref","unstructured":"Seby J, Tavee J, Jehi L. Paraneoplastic Posterior Reversible Encephalopathy Syndrome (PRES) as a Harbinger of Lung Cancer. Neurology. 2013; 80(7).","DOI":"10.1212\/WNL.80.7_supplement.P06.210"},{"issue":"1","key":"10.1016\/j.gore.2017.02.010_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11060-016-2078-0","article-title":"Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study","volume":"128","author":"Kamiya-matsuoka","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.gore.2017.02.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007995","article-title":"Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient","volume":"2013","author":"Abbas","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.gore.2017.02.010_bb0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000435805","article-title":"A grave outcome of posterior reversible encephalopathy syndrome in a patient receiving Avastin (bevacizumab) for metastatic high-grade serous ovarian cancer","volume":"8","author":"Elmalik","year":"2015","journal-title":"Case Rep Oncol."},{"issue":"6","key":"10.1016\/j.gore.2017.02.010_bb0075","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/02841860410018494","article-title":"Severe neurotoxicity caused by gemcitabine treatment","volume":"43","author":"Larsen","year":"2004","journal-title":"Acta Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578917300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578917300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:53:48Z","timestamp":1762480428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578917300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":15,"alternative-id":["S2352578917300218"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2017.02.010","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2017.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}